Deletion of Ac‐NMePhe1from [NMePhe1]arodyn under acidic conditions, part 2: Effects of substitutions on pharmacological activity
Authors:
- 20 January 2011
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 96 (1) , 103-110
Abstract
Arodyn (Ac[Phe1,2,3,Arg4,D‐Ala8]Dyn A(1–11)NH2) is an acetylated dynorphin A (Dyn A) analog that is a potent and selective κ opioid receptor antagonist (Bennett et al., J Med Chem 2002, 45, 5617), and its analog [NMePhe1]arodyn shows even higher affinity and selectivity for κ opioid receptors (Bennett et al., J Pept Res 2005, 65, 322). However, the latter compound is prone to deletion of the Ac‐NMePhe moiety from the N‐terminus of the peptide during acidic cleavage as described in the accompanying paper. Several stable analogs of [NMePhe1]arodyn and [NMePhe1,Trp3]arodyn where the acetyl group was substituted with a heteroatom‐containing group were evaluated for their opioid receptor affinity, selectivity, and efficacy. Methoxycarbonyl derivatives exhibited the highest κ opioid receptor affinity among the analogs. Additional [CH3OCO‐NMePhe1]arodyn analogs where position 3 was substituted with other aromatic or nonaromatic residues were also evaluated for κ receptor affinity, selectivity, and efficacy. [CH3OCO‐NMePhe1]arodyn has similar κ opioid receptor affinity as [NMePhe1]arodyn, retains high κ opioid receptor selectivity, and is a potent κ opioid receptor antagonist. © 2010 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 96: 103–110, 2011.Keywords
This publication has 35 references indexed in Scilit:
- Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynEuropean Journal of Pharmacology, 2007
- Structure–activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist*,†Chemical Biology & Drug Design, 2005
- Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- A Novel N-Terminal Cyclic Dynorphin A AnaloguecycloN,5[Trp3,Trp4,Glu5] Dynorphin A-(1−11)NH2That Lacks the Basic N-TerminusJournal of Medicinal Chemistry, 2003
- Identification of Arodyn, a Novel Acetylated Dynorphin A-(1−11) Analogue, as a κ Opioid Receptor AntagonistJournal of Medicinal Chemistry, 2002
- Identification of the First trans-(3R,4R)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist ActivityJournal of Medicinal Chemistry, 2001
- An open-label study of a functional opioid κ antagonist in the treatment of opioid dependenceJournal of Substance Abuse Treatment, 2000
- A Novel Acetylated Analogue of Dynorphin A-(1−11) Amide as a κ-Opioid Receptor AntagonistJournal of Medicinal Chemistry, 1999
- Optimization of solid-phase synthesis of [Ala8]-dynorphin AThe Journal of Organic Chemistry, 1992
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973